Notices Regarding Patents Sample Clauses

Notices Regarding Patents. All notices, inquiries and communications in connection with this Article IV shall be sent in the manner set forth in Section 9.7 to the Parties at the addresses and facsimile numbers indicated below. If to Licensor: AtheroGenics, Inc. 8995 Xxxxxxxx Xxxxxxx Xxxxxxxxxx, Xxxxxxx 00000 Attn.: Vice President, Business Development (with a copy to: President) Fax No.: (678) 000-0000 If to SPL: Schering Corporation 2000 Xxxxxxxxx Xxxx Xxxx Xxxxxxxxxx, Xxx Xxxxxx 00000 Attn.: Staff Vice President - Patents and Trademarks Fax No.: (908) 000-0000
AutoNDA by SimpleDocs
Notices Regarding Patents. All notices, inquiries and communications in connection with this Article IV shall be sent in the manner set forth in Section 9.7 to the Parties at the addresses and facsimile numbers indicated below. If to Licensor: AtheroGenics, Inc. 8995 Xxxxxxxx Xxxxxxx Xxxxxxxxxx, Xxxxxxx 00000 Attn.: Vice President, Business Development (with a copy to: President) Fax No.: (678) 000-0000
Notices Regarding Patents. All notices, inquiries and communications in connection with this Article IV shall be sent in the manner set forth in Section 9.7 to the parties at the addresses and facsimile numbers indicated below. If to Sparta: Sparta Pharmaceuticals, Inc. 000 Xxxx Xxxx Xxxxxxx, Xxxxxxxxxxxx 00000-0000 Attn.: Chief Executive Officer Fax No. (000) 000-0000 If to Schering: Schering Corporation 0000 Xxxxxxxxx Xxxx Xxxx Xxxxxxxxxx, Xxx Xxxxxx 00000 Attn.: Staff Vice President - Patents and Trademarks Fax No.: (000) 000-0000
Notices Regarding Patents. All notices, inquiries and communications in connection with this Article IV shall be sent in the manner set forth in Section 9.7 to the parties at the addresses and facsimile numbers indicated below. If to Sepracor: Sepracor Inc. 111 Xxxxx Xxxxx Marlborough, Massachusetts 01752-1146 Attn.: Corporate Patent Counsel Fax No.: (508) 000-0000 Xx to Schering: Schering Corporation 2000 Xxxxxxxxx Xxxx Xxxx Xxxxxxxxxx, Xxx Xxxxxx 00000 Attn.: Staff Vice President - Patents and Trademarks Fax No.: (908) 000-0000
Notices Regarding Patents. All notices, inquiries and communications in connection with this Article IV shall be sent in the manner set forth in Section 13.7 to the Parties at the addresses and facsimile numbers indicated below. If to Apollo: Apollo BioPharmaceutics, Inc. Xxx Xxxxxxxx Xxxxx 000 Xxxxxxxxx, Xxxxxxxxxxxxx 00000 Attn.: President Fax No.: (000) 000-0000 with a copy to: Xxxxxx & Dodge Xxx Xxxxxx Xxxxxx Xxxxxx, Xxxxxxxxxxxxx 00000 Attn.: [ * CON * ] Fax No.: (000) 000-0000 If to AHPC: American Home Products Corporation Xxx Xxxxxx Xxxxx Xxxxxxxxxx, Xxx Xxxxxx 00000 Attn.: Senior Vice President Patent and Trademark Department Fax No.: (000) 000-0000
Notices Regarding Patents. 28 VII. CONFIDENTIALITY AND PUBLICATION

Related to Notices Regarding Patents

  • Patents and Patent Applications To the Company’s knowledge, all patents and patent applications owned by or licensed to the Company or under which the Company has rights have been duly and properly filed and maintained; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the USPTO in connection with such applications; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which could reasonably be expected to preclude the grant of a patent in connection with any such application or could reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect to such applications.

  • Patents and Infringement 8.1 Subsequent to the EFFECTIVE DATE, LICENSORS shall continue to have responsibility, at their shared expense, for filing, prosecuting and maintaining their jointly owned patent applications in the USPTO on TECHNOLOGY; DUKE shall continue to have responsibility, at its own expense, for filing, prosecuting and maintaining its solely owned patent applications in the USPTO on DUKE TECHNOLOGY; and MVP shall continue to have responsibility, at its own expense, for filing, prosecuting and maintaining its solely owned patent applications in the USPTO on MVP TECHNOLOGY. LICENSORS shall keep LICENSEE advised as to the prosecution of such applications by forwarding to LICENSEE copies of all official correspondence relating thereto, and shall give LICENSEE an opportunity to comment on all applications, responses to Office Actions, Declarations and other papers before they are filed with the USPTO, and shall consult with LICENSEE concerning the scope of allowed claims before paying any issue fee.

  • Proprietary Rights Notices Licensee agrees that it will not remove, alter or otherwise obscure any proprietary rights notices appearing in the PS Licensed Products, Omega Browser, PS SDK, PS Development Environment and PS Materials. Further, Licensee agrees that it will cause to appear on the container or label for each unit of the Licensee Products manufactured hereunder appropriate patent and copyright notices and proprietary data legends as contained in the PS Licensed Products, Omega Browser, PS SDK, PS Development Environment and PS Materials delivered by PalmSource or as otherwise reasonably required by PalmSource.

  • Intellectual Property and Information Technology (a) Section 5.20(a) of the Company Disclosure Schedule contains a true and complete list, as of the date of this Agreement, of all Company Products.

  • Patent Applications It is understood by the parties that, pursuant to the Baylor Technology Transfer Agreement, MAS has the initial responsibility for filing, prosecution and maintenance of Patents and Patent Applications covering the Baylor Technology. The parties agree that, as between MAS and CTI, MAS shall be responsible for deciding whether and how to file, prosecute and maintain the Patents and Patent Applications, provided that:

  • Intellectual Property, Inventions and Patents Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not patentable) which relate to Parent’s or any of its Subsidiaries’ actual or anticipated business, research and development or existing or future products or services and which are conceived, developed or made by Executive (whether alone or jointly with others) while employed by the Company and its Subsidiaries, whether before or after the date of this Agreement (“Work Product”), belong to Parent, the Company or such Subsidiary. Executive shall promptly disclose such Work Product to the Board and, at the Company’s expense, perform all actions reasonably requested by the Board (whether during or after the Employment Period) to establish and confirm such ownership (including, without limitation, assignments, consents, powers of attorney and other instruments).

  • Proprietary Notices Employee shall not, and shall not permit any other person to, remove any proprietary or other legends or restrictive notices contained in or included in any Confidential Information.

  • Intellectual Property Infringement To the knowledge of the Company and the Operating Partnership and except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor any of its Subsidiaries has infringed or is infringing the intellectual property of a third party, and neither the Company nor any of its Subsidiaries has received notice of a claim by a third party to the contrary, except for any such notice that would not reasonably be expected to have a Material Adverse Effect.

  • Prosecution of Patent Applications At its own expense, each Assignor shall diligently prosecute all material applications for (i) United States Patents listed in Annex F hereto and (ii) Copyrights listed on Annex G hereto, in each case for such Assignor and shall not abandon any such application prior to exhaustion of all administrative and judicial remedies (other than applications deemed by such Assignor to be no longer prudent to pursue), absent written consent of the Collateral Agent.

  • No Notice of Infringement To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has received notice from any third party that the operation of the business of the Company or any of its Subsidiaries or any act, product or service of the Company or any of its Subsidiaries, infringes or misappropriates the Intellectual Property of any third party or constitutes unfair competition or unfair trade practices under the laws of any jurisdiction.

Time is Money Join Law Insider Premium to draft better contracts faster.